Quick Facts

Also known asN-Acetyl Semax Amidate, Enhanced Semax, Modified Semax
CategoryCognitive
Half-life2 hours
Routesintranasal, subcutaneous
Molecular weight1007.16 Da
Chain length7 amino acids
SequenceAsn-Ala-Met-Glu-His-Phe-Pro-Gly-Pro-NH2
FDA statusNot approved
Storage2-8°C (refrigerated). Reconstituted: 21 days.

Dosing Protocols

Goal Dose Frequency Route Cycle Notes
Cognitive Enhancement 600 mcg 1x/day intranasal 4 weeks 600 mcg intranasal spray, 2-3 drops per nostril, 10-30 day cycles.
Mental Fatigue Resistance 800 mcg 1x/day intranasal 4 weeks 800 mcg intranasal spray once daily.
Memory Enhancement 600 mcg 2x/day intranasal 4 weeks 600 mcg 2x daily intranasal spray.
Neuroprotection 1.2 mg 1x/day intranasal 4 weeks 1200 mcg intranasal spray once daily.
Research Protocol (SubQ) 200 mcg 1x/day subcutaneous 3 weeks 200 mcg once daily SubQ, 7-21 day cycles.
Neuroprotection Study (SubQ) 400 mcg 1x/day subcutaneous 3 weeks 400 mcg once daily SubQ.

Protocols shown are for informational purposes only. Consult a healthcare provider before starting any peptide protocol.

Track Your NA Semax Amidate Protocol

Log doses, manage vial inventory, set injection reminders, and visualize blood concentration levels.

Start Tracking — Free

Common Questions

What is the typical dose of NA Semax Amidate?
A common dose for NA Semax Amidate is 600 mcg 1x/day via intranasal. 600 mcg intranasal spray, 2-3 drops per nostril, 10-30 day cycles.
What is the half-life of NA Semax Amidate?
The half-life of NA Semax Amidate is approximately 2 hours. This determines how long the peptide remains active in your body and influences dosing frequency.
How should I store NA Semax Amidate?
Store NA Semax Amidate at 2-8°C (refrigerated). Intranasal administration preferred for CNS bioavailability. More stable than unmodified Semax due to terminal modifications. Store nasal solutions refrigerated. Once reconstituted, use within 21 days.
Is NA Semax Amidate FDA approved?
NA Semax Amidate is not FDA approved and is available for research purposes only. It has not been evaluated by the FDA for safety or efficacy in humans.

References

Related Peptides